WILMINGTON, N.C., Jan. 7 /PRNewswire/ -- Inclinix, Inc., an enrollment
contract research organization (CRO) and provider of clinical trial
recruitment solutions, today announced that the company has closed $10
million in expansion funding from Frontier Capital. Frontier is a private
equity firm providing growth equity to business services companies.
Inclinix accelerates the clinical trials of new drugs by delivering
qualified doctors and patients for enrollment. The company will use the
investment to fund further enhancement of its proprietary enrollment
processes and technologies. Inclinix will also add sales, marketing, and
service delivery resources and expand its corporate facilities.
"We are excited about this investment, which will help us continue the
tremendous growth of our company," said J. Tobin Geatz, president and CEO.
"Inclinix has grown 40 percent annually the past three years and sought
capital to better serve our customers and accelerate our expansion. We will
continue to provide industry-leading enrollment services and technologies
to some of the world's largest pharmaceutical, biopharmaceutical and
medical device companies on a global basis."
Michael Ramich, partner at Frontier Capital, said, "After watching
Inclinix's progress and growth over the past few years, we have been
significantly impressed. They have proven expertise in delivering
enrollment solutions to the leading sponsors conducting clinical research
today. We are pleased to make this commitment and look forward to
supporting Inclinix's continued growth and development as a leading CRO."
About Inclinix
Founded in 1999, Inclinix, Inc., is the industry's Enrollment CRO.
Inclinix's IQM(TM) Intelligent Enrollment process uses technology to
amplify traditional services and is proven to accelerate trials for
pharmaceutical, biotechnology and medical-device organizations. In addition
to its clinical research-related offerings, Inclinix provides strategic
medical marketing communications and adherence services to the healthcare
industry. For more information on Inclinix, visit http://www.inclinix.com
About Frontier Capital
Frontier Capital is a private equity firm providing growth equity to
business service companies. These companies range from traditional to tech-
enabled and deliver a differentiated service to their customers. They have
a proven solution in the marketplace and need capital to accelerate growth,
make acquisitions, or generate shareholder liquidity. The firm is based in
Charlotte, N.C. and provides $5-$10 million per investment in companies
throughout the Southeast and Mid-Atlantic regions. For more information on
Frontier Capital, visit http://www.frontiercapital.com.
SOURCE Inclinix, Inc.
 back to top
Related links:
http://www.inclinix.com
http://www.frontiercapital.com
CONTACT:
Bill Gwinn, +1-910-332-2640,
bgwinn@inclinix.com, or Ruth Dobson, +1-910-332-2045,
rdobson@inclinix.com, both of Inclinix, Inc.
|
